Filter Results:
(1,405)
Show Results For
- All HBS Web
(3,282)
- Faculty Publications (1,405)
Show Results For
- All HBS Web
(3,282)
- Faculty Publications (1,405)
- March 2008 (Revised June 2008)
- Case
Healthcare and Harvard Business School Alumni in 2008
By: Richard G. Hamermesh, Carin-Isabel Knoop and Cara Sterling
This case chronicles the role that Harvard Business School alumni play in the healthcare industry. Overall data on alumni is given, and the industry is broken into seven areas in which the careers of twenty-five alumni are highlighted. View Details
Keywords: Business Education; Executive Education; Personal Development and Career; Practice; Health Industry
Hamermesh, Richard G., Carin-Isabel Knoop, and Cara Sterling. "Healthcare and Harvard Business School Alumni in 2008." Harvard Business School Case 808-044, March 2008. (Revised June 2008.)
- March 2008
- Case
The Multiple Sclerosis Center of Atlanta
By: Regina E. Herzlinger and Alfred Martin
The Multiple Sclerosis Center of Atlanta wishes to expand beyond Georgia. The factors influencing this decision are discussed, including drug treatments currently available, and the impact of future drugs in the FDA pipeline as well as financing issues. View Details
Keywords: Decision Choices and Conditions; Financing and Loans; Health Care and Treatment; Health Disorders; Medical Specialties; Expansion; Health Industry; Atlanta
Herzlinger, Regina E., and Alfred Martin. "The Multiple Sclerosis Center of Atlanta." Harvard Business School Case 308-085, March 2008.
- March 2008 (Revised April 2008)
- Teaching Note
Cleveland Clinic (TN)
By: Frances X. Frei, Amy C. Edmondson and Christine Harris-Van Keuren
Teaching Note for [607143]. View Details
Keywords: Health Industry
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,... View Details
Keywords: Innovation and Invention; Resource Allocation; Product Development; Partners and Partnerships; Research and Development; Science-Based Business; Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- 2008
- Case
Eli Lilly: Recreating Drug Discovery for the 21st Century
By: Rebecca Henderson and C. Reavis
- February 2008
- Teaching Note
DermaCare: Zapping Zits Directly (TN)
Teaching Note for [808064]. View Details
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test. View Details
Keywords: Health Testing and Trials; Genetics; Science-Based Business; Commercialization; Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- February 2008
- Teaching Note
ThedaCare: System Strategy (TN)
By: Michael E. Porter and Sachin H. Jain
Teaching Note for 708-424. View Details
- February 2008 (Revised August 2012)
- Background Note
Note on Medical Travel
By: Regina E. Herzlinger and Sara Green
Background notes for MedVal and Fortis case studies. View Details
Keywords: Cost; Health Care and Treatment; Cross-Cultural and Cross-Border Issues; Health Industry; Health Industry; India
Herzlinger, Regina E., and Sara Green. "Note on Medical Travel." Harvard Business School Background Note 308-084, February 2008. (Revised August 2012.)
- February 2008 (Revised August 2014)
- Case
MedVal Ventures
Is medical travel a viable business opportunity? A group of MBA students consider the pros and cons of starting a business that would send people from the U.S. to India for elective non-emergency surgeries. View Details
Keywords: Business Startups; Cost Management; Globalized Markets and Industries; Health Care and Treatment; Health Industry; Health Industry; India; United States
Herzlinger, Regina E. "MedVal Ventures." Harvard Business School Case 308-087, February 2008. (Revised August 2014.)
- January 2008 (Revised May 2009)
- Case
Restructuring at Delphi Corporation (A)
By: Stuart C. Gilson and Sarah L. Abbott
Delphi Corporation, operating under Chapter 11 bankruptcy protection, has filed a plan of reorganization with the court, under which a consortium of hedge funds led by Appaloosa Management will invest up to $2.6 billion in new equity. Also participating in the plan is... View Details
Keywords: Restructuring; Capital Structure; Private Equity; Insolvency and Bankruptcy; Investment Funds; Labor and Management Relations; Auto Industry; Auto Industry
Gilson, Stuart C., and Sarah L. Abbott. "Restructuring at Delphi Corporation (A)." Harvard Business School Case 208-069, January 2008. (Revised May 2009.)
- January 2008 (Revised August 2012)
- Case
Retail Sales of Health Insurance: Blue Cross Blue Shield of Florida
By: Regina E. Herzlinger and Grady Clouse
The BCBS of Florida is contemplating whether to enter the consumer-driven health care market and if so, whether to target such groups—and individuals—and in which of its geographic markets, and how. View Details
- December 2007 (Revised April 2008)
- Case
Alltech...naturally
By: David E. Bell and Mary L. Shelman
Entrepreneur Pearse Lyons had built Alltech into the fastest growing company in the global animal health industry through innovative technology, creative marketing, and strong branding. Sel-Plex, a proprietary Alltech product, had shown important health benefits for... View Details
Keywords: Brands and Branding; Leadership Development; Customer Focus and Relationships; Expansion; Technological Innovation; Intellectual Property; Sales; Value Creation; Business Model; Growth and Development Strategy; Health Industry
Bell, David E., and Mary L. Shelman. "Alltech...naturally." Harvard Business School Case 508-033, December 2007. (Revised April 2008.)
- December 2007 (Revised January 2008)
- Teaching Note
Eli Lilly: Developing Cymbalta (TN)
By: Elie Ofek
Teaching Note for 507-044 View Details
- December 2007 (Revised January 2008)
- Case
Transforming Arizona's Health Care System: Developing and Implementing the Health-e Connection Roadmap
By: Lynda M. Applegate, Ajay Vinze, T.S. Raghu and Minu Ipe
Addresses the issues of leadership and change management in the process of transforming an industry through an innovative public-private partnership approach to policy making. In 2005, the Governor of Arizona issued an Executive Order to create a roadmap for the state... View Details
Keywords: Change Management; Transformation; Private Sector; Public Sector; Health Care and Treatment; Service Delivery; Partners and Partnerships; Information Technology; Health Industry; Health Industry
Applegate, Lynda M., Ajay Vinze, T.S. Raghu, and Minu Ipe. "Transforming Arizona's Health Care System: Developing and Implementing the Health-e Connection Roadmap." Harvard Business School Case 808-072, December 2007. (Revised January 2008.)
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Biotechnology Industry; Biotechnology Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- November 2007
- Case
Center for Integration of Medicine and Innovative Technology (CIMIT)
By: H. Kent Bowen and Courtney Purrington
Translating innovative ideas form the clinician to the patient remains a major problem in the field of medicine. Dr. John Parrish and colleagues created an organization (CIMIT) that brings the technical, financial, and administrative resources to these innovative... View Details
Keywords: Financing and Loans; Innovation and Invention; Technological Innovation; Resource Allocation; Alliances; Research and Development; Health Industry; Health Industry
Bowen, H. Kent, and Courtney Purrington. "Center for Integration of Medicine and Innovative Technology (CIMIT)." Harvard Business School Case 608-036, November 2007.
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Biotechnology Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- November 2007 (Revised January 2010)
- Case
ThedaCare: System Strategy
By: Michael E. Porter and Sachin H. Jain
Over the 1980s and 1990s, America's changing health care payer environment resulted in mergers of numerous community hospitals into hospital systems. Based in Appleton, Wisconsin, ThedaCare stood out among community hospital systems in its pursuit of service... View Details
Keywords: Value Creation; Health Care and Treatment; Problems and Challenges; Innovation and Invention; Health Industry; Wisconsin
Porter, Michael E., and Sachin H. Jain. "ThedaCare: System Strategy." Harvard Business School Case 708-424, November 2007. (Revised January 2010.)
- October 2007
- Case
Colgate Max Fresh: Global Brand Roll-Out
By: John A. Quelch
In February 2005, Nigel Burton, in his third year as president of global oral care at Colgate-Palmolive Company (CP), had every reason to feel optimistic. Worldwide market shares were strong and Colgate Max Fresh (CMF), a new toothpaste that had helped drive Colgate to... View Details
Keywords: Marketing Strategy; Product Launch; Global Strategy; Brands and Branding; Consumer Products Industry; Consumer Products Industry; China; Mexico
Quelch, John A., and Jacquie Labatt-Randle. "Colgate Max Fresh: Global Brand Roll-Out." Harvard Business School Case 508-009, October 2007.